company background image
6677 logo

Anxo Pharmaceutical TPEX:6677 Stock Report

Last Price

NT$40.90

Market Cap

NT$2.3b

7D

-5.2%

1Y

-26.0%

Updated

13 Jul, 2024

Data

Company Financials

Anxo Pharmaceutical Co., Ltd.

TPEX:6677 Stock Report

Market Cap: NT$2.3b

6677 Stock Overview

A specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally.

6677 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Anxo Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Anxo Pharmaceutical
Historical stock prices
Current Share PriceNT$40.90
52 Week HighNT$63.00
52 Week LowNT$39.65
Beta-0.073
11 Month Change-7.26%
3 Month Change-11.57%
1 Year Change-26.04%
33 Year Change75.29%
5 Year Change24.51%
Change since IPO-14.92%

Recent News & Updates

Recent updates

These 4 Measures Indicate That Anxo Pharmaceutical (GTSM:6677) Is Using Debt Extensively

Dec 30
These 4 Measures Indicate That Anxo Pharmaceutical (GTSM:6677) Is Using Debt Extensively

Should We Be Cautious About Anxo Pharmaceutical Co., Ltd.'s (GTSM:6677) ROE Of 2.4%?

Nov 25
Should We Be Cautious About Anxo Pharmaceutical Co., Ltd.'s (GTSM:6677) ROE Of 2.4%?

Shareholder Returns

6677TW PharmaceuticalsTW Market
7D-5.2%-3.6%1.3%
1Y-26.0%15.2%36.7%

Return vs Industry: 6677 underperformed the TW Pharmaceuticals industry which returned 15.2% over the past year.

Return vs Market: 6677 underperformed the TW Market which returned 36.7% over the past year.

Price Volatility

Is 6677's price volatile compared to industry and market?
6677 volatility
6677 Average Weekly Movement3.2%
Pharmaceuticals Industry Average Movement4.5%
Market Average Movement4.8%
10% most volatile stocks in TW Market8.6%
10% least volatile stocks in TW Market2.3%

Stable Share Price: 6677 has not had significant price volatility in the past 3 months.

Volatility Over Time: 6677's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003n/an/awww.anxo.com.tw

Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. The company offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. It also offers drugs for antidiabetic/dyslipidaemic agents, cardiovascular/circulatory system, nervous system, hepatology/gastroenterology, anti-infectives/anti-viruses, hemodialysis/urinary system, respiratory system/antihistamine, analgesics, and others; and injections. The company was founded in 2003 and is headquartered in Taipei, Taiwan.

Anxo Pharmaceutical Co., Ltd. Fundamentals Summary

How do Anxo Pharmaceutical's earnings and revenue compare to its market cap?
6677 fundamental statistics
Market capNT$2.28b
Earnings (TTM)NT$21.86m
Revenue (TTM)NT$939.94m

104.1x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6677 income statement (TTM)
RevenueNT$939.94m
Cost of RevenueNT$543.01m
Gross ProfitNT$396.93m
Other ExpensesNT$375.07m
EarningsNT$21.86m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.39
Gross Margin42.23%
Net Profit Margin2.33%
Debt/Equity Ratio62.7%

How did 6677 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

93%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.